Dillon RL - Search Results

1

Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald G, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH. Patterson AM, et al. Among authors: dillon rl. Mol Cancer Ther. 2016 Feb;15(2):313-22. doi: 10.1158/1535-7163.MCT-15-0658. Epub 2015 Dec 30. Mol Cancer Ther. 2016. PMID: 26719579 Free PMC article.

2

Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance.

Dillon RL, Chooniedass S, Premsukh A, Adams GP, Entwistle J, MacDonald GC, Cizeau J. Dillon RL, et al. J Immunother. 2016 Apr;39(3):117-26. doi: 10.1097/CJI.0000000000000115. J Immunother. 2016. PMID: 26938945

3

DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents.

Chooniedass S, Dillon RL, Premsukh A, Hudson PJ, Adams GP, MacDonald GC, Cizeau J. Chooniedass S, et al. Among authors: dillon rl. Molecules. 2016 Dec 17;21(12):1741. doi: 10.3390/molecules21121741. Molecules. 2016. PMID: 27999336 Free PMC article.

4

Distinct biological roles for the akt family in mammary tumor progression.

Dillon RL, Muller WJ. Dillon RL, et al. Cancer Res. 2010 Jun 1;70(11):4260-4. doi: 10.1158/0008-5472.CAN-10-0266. Epub 2010 Apr 27. Cancer Res. 2010. PMID: 20424120 Free PMC article. Review.

5

The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.

Basak P, Dillon R, Leslie H, Raouf A, Mowat MR. Basak P, et al. BMC Cancer. 2015 Sep 9;15:630. doi: 10.1186/s12885-015-1642-x. BMC Cancer. 2015. PMID: 26353792 Free PMC article.

6

Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.

Dillon RL, Marcotte R, Hennessy BT, Woodgett JR, Mills GB, Muller WJ. Dillon RL, et al. Cancer Res. 2009 Jun 15;69(12):5057-64. doi: 10.1158/0008-5472.CAN-08-4287. Epub 2009 Jun 2. Cancer Res. 2009. PMID: 19491266 Free PMC article.

7

In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.

Basak P, Leslie H, Dillon RL, Muller WJ, Raouf A, Mowat MRA. Basak P, et al. Among authors: dillon rl. Genes Chromosomes Cancer. 2018 Apr;57(4):182-191. doi: 10.1002/gcc.22519. Epub 2017 Dec 29. Genes Chromosomes Cancer. 2018. PMID: 29218825

8

HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.

Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, Cardiff RD, Newman RA, Yang P, Thaler HT, Muller WJ, Hudis C, Brown AM, Hla T, Subbaramaiah K, Dannenberg AJ. Howe LR, et al. Cancer Res. 2005 Nov 1;65(21):10113-9. doi: 10.1158/0008-5472.CAN-05-1524. Cancer Res. 2005. PMID: 16267038

9

An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer.

Dillon RL, Brown ST, Ling C, Shioda T, Muller WJ. Dillon RL, et al. Mol Cell Biol. 2007 Dec;27(24):8648-57. doi: 10.1128/MCB.00866-07. Epub 2007 Oct 15. Mol Cell Biol. 2007. PMID: 17938205 Free PMC article.

10

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer.

Dillon RL, White DE, Muller WJ. Dillon RL, et al. Oncogene. 2007 Feb 26;26(9):1338-45. doi: 10.1038/sj.onc.1210202. Oncogene. 2007. PMID: 17322919 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters